U.S. Anesthesia Partners, Inc. Antitrust Litigation
Lieff Cabraser represents plaintiffs in a class action alleging that U.S. Anesthesia Partners, Inc. monopolized the commercially reimbursed hospital-only anesthesia market in Texas. Between 2012 and 2019, USAP acquired sixteen anesthesia practices across Texas as a part of an “aggressive ‘buy and build’ consolidation strategy.” Through those acquisitions, USAP obtained more than 50% of the Texas market. USAP transformed its growing market share and foothold in multiple geographies across Texas into profits. After each acquisition, USAP raised reimbursement rates above competitive levels. As a result, Texas healthcare payors have been illegally overcharged for anesthesia services since 2012.
This class action parallels the Federal Trade Commission’s civil lawsuit against USAP, which alleges that USAP monopolized the commercially reimbursed hospital-only anesthesia market in Texas.
Civil Litigation News
San Francisco Schools Receive Financial Boost From Settlement With JUUL
As reported by the S.F. Chronicle, the San Francisco Unified School District has been awarded a substantial $24.65 million payment from vaping
Final Approval Granted to Historic $235M Settlement with Altria in National JUUL Youth E-Cigarette Predatory Advertising, Addiction and Injury Litigation
On March 14, 2024, U.S. District Judge William Orrick of the Northern District of California issued an order granting final approval to a comprehensive
New York Times Spotlights Lieff Cabraser’s Recent Win on Behalf of Hawaiian Kona Coffee Farmers
The New York Times has published an exemplary piece highlighting Lieff Cabraser’s leadership in securing a pivotal victory for Kona coffee farmers
